What is the Global market size of Hospital-Acquired Infection Control Market?

Global Hospital-Acquired Infection Control Market size was valued at USD 31,990.67 million in 2021 and is poised to grow from USD 32.998.89 million in 2022 to USD 60,675.15 million by 2030, growing at a CAGR of 7.3% in the forecast period (2023-2030).

Hospital-Acquired Infection Control Market Size, Share, Growth Analysis, By Product & Service Sterilization(Sterilization, Sterilization Product, Heat Sterilization Equipment, Low Temperature Sterilization Equipment), By Infection(Hospital-acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections), By End-User(Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region - Industry Forecast 2024-2031

Q: Who are the key vendors in the Global Hospital-Acquired Infection Control Market?

The competitive environment of the global hospital-acquired infection control market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry. '3M Company', 'Becton, Dickinson and Company', 'STERIS plc', 'Getinge AB', 'Tuttnauer Ltd.', 'Olympus Corporation', 'Xenex Disinfection Services Inc.', 'ASP (Advanced Sterilization Products)', 'Ecolab', 'Belimed AG', 'KCWW (Kimberly-Clark Worldwide, Inc.)', 'MATACHANA GROUP ', 'MMM Group ', 'Belimed AG ', 'Reckitt Benckiser ', 'Metrex Research LLC '

Report ID: SQMIG35A2598 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 104 | Figures: 72

Hospital-Acquired Infection Control Market Regional Insights

North America emerged as the dominant force within the market, securing a substantial revenue share exceeding 34.0% in 2022. This commanding presence can be attributed to several key factors shaping the region's healthcare landscape. The region boasts the presence of key industry players actively engaged in combating Hospital Acquired Infections (HAIs) through comprehensive initiatives spanning both public and private sectors.

In the Asia Pacific region, the market is forecasted to experience a notable CAGR of 5.7% in the coming years, signifying robust growth prospects. This upward trajectory is primarily attributed to two key factors shaping the healthcare landscape in the region. There's a rising prevalence of Hospital Acquired Infections (HAIs) within healthcare facilities across various Asian countries.

Hospital-Acquired Infection Control Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Hospital-Acquired Infection Control Market size was valued at USD 32,998.89 million in 2022 and is poised to grow from USD 34,007.11 million in 2023 to USD 44,062.37 million by 2031, growing at a CAGR of 7.3% in the forecast period (2024-2031).

The competitive environment of the hospital-acquired infection control market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry. '3M Company', 'Becton, Dickinson and Company', 'STERIS plc', 'Getinge AB', 'Tuttnauer Ltd.', 'Olympus Corporation', 'Xenex Disinfection Services Inc.', 'ASP (Advanced Sterilization Products)', 'Ecolab', 'Belimed AG', 'KCWW (Kimberly-Clark Worldwide, Inc.)', 'MATACHANA GROUP', 'MMM Group', 'Belimed AG', 'Reckitt Benckiser', 'Metrex Research LLC'

In recent years, there has been a substantial upsurge in the count of surgical procedures conducted annually. As per the World Health Organization's data from 2022, an estimated 330 million major surgical procedures are carried out worldwide each year. Several factors contribute to this remarkable increase. The prevalence of conditions like obesity and various lifestyle-related diseases has been steadily rising, necessitating surgical interventions for treatment and management.

Ethylene oxide stands out as one of the most efficient gaseous sterilizing agents, particularly suitable for instruments that are sensitive to high temperatures, such as plastic instruments or those incorporating electrical components. Despite its efficacy, concerns have been raised regarding the potential health risks associated with ethylene oxide exposure.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Hospital-Acquired Infection Control Market Regional Insights

Hospital-Acquired Infection Control Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Hospital-Acquired Infection Control Market?

Who are the key vendors in the Hospital-Acquired Infection Control Market?

What is the key driver of Hospital-Acquired Infection Control Market?

What is the key market trend for Hospital-Acquired Infection Control Market?

Which region accounted for the largest share in Hospital-Acquired Infection Control Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300